The neurobiology and treatment of first-episode schizophrenia.
about
Early interventions in risk groups for schizophrenia: what are we waiting for?From Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids MetabolismEarly auditory processing evoked potentials (N100) show a continuum of blunting from clinical high risk to psychosis in a pediatric sampleMolecular substrates of schizophrenia: homeostatic signaling to connectivityLY395756, an mGluR2 agonist and mGluR3 antagonist, enhances NMDA receptor expression and function in the normal adult rat prefrontal cortex, but fails to improve working memory and reverse MK801-induced working memory impairment.Neuroimaging findings from childhood onset schizophrenia patients and their non-psychotic siblings.In vivo imaging of neuroinflammation in schizophreniaA Neurophysiological Perspective on a Preventive Treatment against Schizophrenia Using Transcranial Electric Stimulation of the Corticothalamic PathwayBorderline personality disorder and childhood trauma: exploring the affected biological systems and mechanismsRelationships between dorsolateral prefrontal cortex metabolic change and cognitive impairment in first-episode neuroleptic-naive schizophrenia patients.The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosisStructural brain changes in schizophrenia at different stages of the illness: A selective review of longitudinal magnetic resonance imaging studies.Brain structure, cognition and negative symptoms in schizophrenia are associated with serum levels of polysialic acid-modified NCAM.Abnormal context-reward associations in an immune-mediated neurodevelopmental mouse model with relevance to schizophrenia.Reduced γ-Aminobutyric Acid and Glutamate+Glutamine Levels in Drug-Naïve Patients with First-Episode Schizophrenia but Not in Those at Ultrahigh RiskSchizophrenia in 2020: Trends in diagnosis and therapy.Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review.Neurocognitive, Neuroprotective, and Cardiometabolic Effects of Raloxifene: Potential for Improving Therapeutic Outcomes in Schizophrenia.Genetic Overlap Between Schizophrenia and Developmental Psychopathology: Longitudinal and Multivariate Polygenic Risk Prediction of Common Psychiatric Traits During Development.Improving Current Treatments for Schizophrenia.Cognitive effects of adjunctive N-acetyl cysteine in psychosis.Oxidative Stress and Inflammation in Early Onset First Episode Psychosis: A Systematic Review and Meta-Analysis.Crossreactivity of an Antiserum Directed to the Gram-Negative Bacterium Neisseria gonorrhoeae with the SNARE-Complex Protein Snap23 Correlates to Impaired Exocytosis in SH-SY5Y Cells.Predicting brain structure in population-based samples with biologically informed genetic scores for schizophrenia.Chinese version of the Schizotypal Personality Questionnaire: Factor structure replication and invariance across sex.Implication of the glutamate-cystine antiporter xCT in schizophrenia cases linked to impaired GSH synthesis.Genetic Variation in Schizophrenia Liability is Shared With Intellectual Ability and Brain Structure.The contribution of neuroimaging to understanding schizophrenia; past, present, and future.Patient satisfaction after acute admission for psychosis.Brain-specific deletion of histone variant H2A.z results in cortical neurogenesis defects and neurodevelopmental disorder.Adjunctive memantine in clozapine-treated refractory schizophrenia: an open-label 1-year extension study.Brain TSPO imaging and gray matter volume in schizophrenia patients and in people at ultra high risk of psychosis: An [(11)C]PBR28 study.Brain-derived neurotrophic factor serum and plasma levels in the treatment of acute schizophrenia with olanzapine or risperidone: 6-week prospective study.Altered Motor-Striatal Plasticity and Cortical Functioning in Patients with Schizophrenia.No progressive brain changes during a 1-year follow-up of patients with first-episode psychosis.Schizophrenia: synthetic strategies and recent advances in drug designResting-state gamma-band power alterations in schizophrenia reveal E/I-balance abnormalities across illness-stages
P2860
Q26747545-A70051F9-D7F4-4594-BA3F-09570CF4A8A8Q28067617-9D87667B-9DA0-4DC6-A9D4-D4255D4BAC62Q30368928-37770A90-6420-4FA8-91EF-4BA742EF6480Q30383611-845D9CE1-B513-4BFA-BCDB-57592C237DF3Q30747587-CC06B11A-1A2B-4C79-82FF-C25DC0DE8A9FQ30918698-4AEA99F4-B025-44FE-9072-CE2A479BA01FQ30966978-734DC01C-F62F-49E2-A9FB-3C84373BC270Q33607904-4EAE7911-0D52-4C2D-A672-441600871271Q33805362-33DF419A-9B7F-4BB3-9AB8-960963A834A1Q33833761-8A10773A-CEBC-4859-B838-87AAD6922D84Q35955612-3C17598D-3EC9-4C10-9808-461A6E22C32DQ36348922-96D76351-98D1-4CA7-B99B-A6B5B180281FQ37058646-B3B2A86A-2525-4629-BC69-576A4177B362Q37347747-761AA614-AC62-446D-BF28-DD4702A09BFFQ37492603-EA174BC9-D23B-45BD-9178-D3C88D4A9444Q38502779-F56B9B28-0335-49E0-968F-50C3D0F84F27Q38647035-46F59F48-50B9-44EB-80C3-858D4F92278CQ38837641-8F2EBECD-CE9A-4B38-A9EF-A4F1A00068ACQ38879526-03077CBB-D4D0-40D5-A58B-2A0121DCE9AEQ38955513-D96A8B0A-4E2A-44E4-942A-62A81D0BF43BQ39147992-9E58A36C-B966-4871-AA3D-C50C31C85601Q39346412-E29B1A4E-91D2-440B-831C-86D0F796D1E6Q40230309-83CD3653-77D7-4E54-B961-EA19FB52D752Q40290207-928B4AF6-57E5-4E51-85A2-83651A37A5CEQ40462639-C9A0ADA2-C186-460A-89AA-C0F5B1CBEA4BQ41701597-722A8EE6-7EDB-496B-834A-9C2EA7810A6CQ41703383-A1EFF6C7-A242-4E93-A5CD-652838EB439CQ42635344-0B1B2796-BD76-4C69-ACC6-E21572638C7CQ47598384-15E0F232-B07E-4670-9847-D3DA4251BED5Q47886733-F405C42B-AD4D-46B5-AC98-794DF5868DFAQ47902795-FEDE6DAE-3C12-4125-A0E1-64DB1CBC7977Q48118494-F513AACD-07AB-4E8E-AECB-D40CA601104EQ48215288-864A8151-F484-43E7-B727-5115B67C88E6Q48431897-0C940261-706D-437A-916F-0793794FC18CQ50556987-B0740D89-2FDA-42C3-A0EB-5733DEFF130BQ57393544-832D7EB9-F47F-4AEC-80BA-8B5AA8B841C2Q59129268-1670FFCB-BE83-47B0-B3D3-184254532045
P2860
The neurobiology and treatment of first-episode schizophrenia.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
The neurobiology and treatment of first-episode schizophrenia.
@en
type
label
The neurobiology and treatment of first-episode schizophrenia.
@en
prefLabel
The neurobiology and treatment of first-episode schizophrenia.
@en
P2860
P356
P1433
P1476
The neurobiology and treatment of first-episode schizophrenia.
@en
P2093
P2860
P2888
P356
10.1038/MP.2014.66
P407
P50
P577
2014-07-22T00:00:00Z
P5875
P6179
1053076414